Invasive and Non-Invasive Ventilation in Patients With COVID-19.


Journal

Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967

Informations de publication

Date de publication:
03 08 2020
Historique:
received: 02 05 2020
revised: 02 05 2020
accepted: 25 06 2020
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 15 9 2020
Statut: ppublish

Résumé

The reported high mortality of COVID-19 patients in intensive care has given rise to a debate over whether patients with this disease are being intubated too soon and might instead benefit from more non-invasive ventilation. This review is based on articles published up to 12 June 2020 that were retrieved by a selective literature search on the topic of invasive and non-invasive ventilation for respiratory failure in COVID-19. Guideline recommendations and study data on patients with respiratory failure in settings other than COVID-19 are also considered, as are the current figures of the intensive care registry of the German Interdisciplinary Association for Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin). The high mortality figures among patients receiving invasive ventilation that have been reported in studies from abroad cannot be uncritically applied to the current situation in Germany. Study data on ventilation specifically in COVID-19 patients would be needed to do justice to the special pathophysiology of this disease, but such data are lacking. Being intubated too early is evidently associated with risks for the patient, but being intubated too late is as well. A particularly im - portant consideration is the potential harm associated with prolonged spontaneous breathing, with or without non-invasive assistance, as any increase in respiratory work can seriously worsen respiratory failure. On the other hand, it is clearly unacceptable to intubate patients too early merely out of concern that the medical staff might become infected with COVID-19 if they were ventilated non-invasively. Nasal high flow, non-invasive ventilation, and invasive ventilation with intubation should be carried out in a stepwise treatment strategy, under appropriate intensive-care monitoring and with the observance of all relevant anti-infectious precautions. Germany is better prepared that other countries to provide COVID-19 patients with appropriate respiratory care, in view of the high per capita density of intensive-care beds and the availability of a nationwide, interdisciplinary intensive care registry for the guidance and coordination of intensive care in patients who need it.

Sections du résumé

BACKGROUND
The reported high mortality of COVID-19 patients in intensive care has given rise to a debate over whether patients with this disease are being intubated too soon and might instead benefit from more non-invasive ventilation.
METHODS
This review is based on articles published up to 12 June 2020 that were retrieved by a selective literature search on the topic of invasive and non-invasive ventilation for respiratory failure in COVID-19. Guideline recommendations and study data on patients with respiratory failure in settings other than COVID-19 are also considered, as are the current figures of the intensive care registry of the German Interdisciplinary Association for Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin).
RESULTS
The high mortality figures among patients receiving invasive ventilation that have been reported in studies from abroad cannot be uncritically applied to the current situation in Germany. Study data on ventilation specifically in COVID-19 patients would be needed to do justice to the special pathophysiology of this disease, but such data are lacking. Being intubated too early is evidently associated with risks for the patient, but being intubated too late is as well. A particularly im - portant consideration is the potential harm associated with prolonged spontaneous breathing, with or without non-invasive assistance, as any increase in respiratory work can seriously worsen respiratory failure. On the other hand, it is clearly unacceptable to intubate patients too early merely out of concern that the medical staff might become infected with COVID-19 if they were ventilated non-invasively.
CONCLUSION
Nasal high flow, non-invasive ventilation, and invasive ventilation with intubation should be carried out in a stepwise treatment strategy, under appropriate intensive-care monitoring and with the observance of all relevant anti-infectious precautions. Germany is better prepared that other countries to provide COVID-19 patients with appropriate respiratory care, in view of the high per capita density of intensive-care beds and the availability of a nationwide, interdisciplinary intensive care registry for the guidance and coordination of intensive care in patients who need it.

Identifiants

pubmed: 32900426
pii: arztebl.2020.0528
doi: 10.3238/arztebl.2020.0528
pmc: PMC7658682
doi:
pii:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-533

Références

JAMA. 2020 Jun 9;323(22):2338-2340
pubmed: 32412606
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
JAMA. 2020 Jun 9;323(22):2336-2338
pubmed: 32412581
Dtsch Arztebl Int. 2020 Mar 20;117(12):197-204
pubmed: 32343653
Am J Respir Crit Care Med. 2017 Jan 1;195(1):67-77
pubmed: 27753501
Pneumologie. 2020 Jan;74(1):46-49
pubmed: 31958870
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
Respiration. 2015;89(4):312-21
pubmed: 25791249
JAMA. 2020 Jun 9;323(22):2329-2330
pubmed: 32329799
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
Dtsch Arztebl Int. 2018 Dec 14;115(50):840-847
pubmed: 30722839
Intensive Care Med. 2012 Oct;38(10):1647-53
pubmed: 22777516
Pneumologie. 2014 Jan;68(1):19-75
pubmed: 24431072
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320
pubmed: 32281885
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Ann Intensive Care. 2018 Mar 16;8(1):38
pubmed: 29549456
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Pneumologie. 2020 Jun;74(6):337-357
pubmed: 32323287
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278
pubmed: 32519944
Int J Legal Med. 2020 Jul;134(4):1275-1284
pubmed: 32500199
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
Crit Care. 2020 Jun 4;24(1):285
pubmed: 32498689
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30705129
Pneumologe (Berl). 2020;17(6):406-425
pubmed: 33110402
Pneumologie. 2015 Dec;69(12):719-756
pubmed: 26649598
Anesthesiology. 2020 Jun;132(6):1317-1332
pubmed: 32195705
Crit Care. 2020 Mar 31;24(1):124
pubmed: 32234064
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442
pubmed: 27626833
Am J Respir Crit Care Med. 2020 Aug 15;202(4):558-567
pubmed: 32325004

Auteurs

Wolfram Windisch (W)

Department of Respiratory Medicine, Kliniken der Stadt Köln gGmbH, University of Witten/Herdecke; Surgical Intensive Care, Department of Anesthesiology, Charité University Medical Center, Berlin; Department of Intensive Care, University Medical Center Hamburg-Eppendorf; Department of Anesthesiology, University Medical Center Aachen, RWTH Aachen University; Director of Patient Care at MHH, The German Center for Lung Research, University Medical School Hanover (MHH), Hanover.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH